Cervical cancer screening: what role for methylation tests?
Virologie · 2026-02 · 30 (1) · 19-32
DOI: 10.1684/vir.2026.1122 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Virologie, 2026-02. Verfasst von Charlotte Charpentier und 3 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, Inserm, IAME, F-75018 Paris, France, Service de Virologie, AP-HP, Hôpital Bichat-Claude Bernard, F-75018 Paris, France. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, DNA Methylation, Early Detection of Cancer, Papillomavirus Infections.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Université Paris Cité, Inserm, IAME, F-75018 Paris, France, Service de Virologie, AP-HP, Hôpital Bichat-Claude Bernard, F-75018 Paris, France.
- Université Paris Cité, Inserm, IAME, F-75018 Paris, France, Service de Bactériologie, AP-HP, Hôpital Saint-Louis, F-75010 Paris, France.
- Sorbonne Université, Inserm, iPLESP, F-75013 Paris, France, Service de Virologie, AP-HP, Hôpital de La Pitié Salpêtrière, F-75013 Paris, France.
Zitieren
APA
Charpentier, C., Brousseau, J., Jary, A., & Ferré, V. M. (2026). Cervical cancer screening: what role for methylation tests?. Virologie, 30(1), 19-32. https://doi.org/10.1684/vir.2026.1122
Vancouver
Charpentier C, Brousseau J, Jary A, Ferré VM. Cervical cancer screening: what role for methylation tests?. Virologie. 2026;30(1):19-32. doi:10.1684/vir.2026.1122
BibTeX
@article{Charpentier2026,
author = {Charpentier, Charlotte and Brousseau, Julie and Jary, Aude and Ferré, Valentine Marie},
title = {Cervical cancer screening: what role for methylation tests?},
journal = {Virologie},
year = {2026},
volume = {30},
number = {1},
pages = {19--32},
doi = {10.1684/vir.2026.1122}
}
EUVIMED